SCHEMBL4937005

SCHEMBL4937005

O=C(O)c1csc(Nc2ccc(Cl)c(C(F)(F)F)c2)n1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DHODH Q02127 3/20 0.56
KDR P35968 1/20 0.50
GRM4 Q14833 1/20 0.50
KDM1A O60341 4/20 0.48
PDK1 Q15118 1/20 0.46
CSNK2A1 P68400 1/20 0.45
BLM P54132 1/20 0.45
TRPV1 Q8NER1 1/20 0.44
MEN1 O00255 1/20 0.44
ALDH1A1 P00352 1/20 0.44
KMT2A Q03164 1/20 0.44
CFTR P13569 2/20 0.43
RAPGEF4 Q8WZA2 1/20 0.43
RAF1 P04049 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA7 P43166 1/20 0.43
CA9 Q16790 1/20 0.43
CSNK2A2 P19784 1/20 0.42
CSNK2B P67870 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL525319 0.84 KDM1A (0.55) KDM1ABLMMEN1KMT2ACSNK2A2
SCHEMBL4363742 0.82 MAPT (0.63) DHODHKDRGRM4PDK1BLM
SCHEMBL14069839 0.80 MAPT (0.54) DHODHKDRGRM4PDK1BLM
SCHEMBL525630 0.79 CFTR (0.54) KDM1ACSNK2A1MEN1KMT2ACFTR
SCHEMBL14070017 0.79 DHODH (0.57) DHODHKDRGRM4PDK1BLM
SCHEMBL4931471 0.79 DHODH (0.52) DHODHKDRGRM4PDK1CSNK2A1
SCHEMBL21852321 0.79 MEN1 (0.56) DHODHKDM1AMEN1ALDH1A1KMT2A
SCHEMBL14069875 0.78 MAPT (0.53) DHODHKDRGRM4PDK1BLM
SCHEMBL14069855 0.78 KCNJ5 (0.56) DHODHKDRGRM4PDK1TRPV1
SCHEMBL5032528 0.78 KDM1A (0.51) GRM4KDM1ACSNK2A1MEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080221088-A1 3,4-Substituted Thiazoles as Ampk Activators DR. REDDY'S LABORATORIES LTD. (IN) 2008-09-11 US disclosed
US-20080221088-A1 3,4-Substituted Thiazoles as Ampk Activators DR. REDDY'S LABORATORIES LTD. (IN) 2008-09-11 US disclosed
US-20080221088-A1 3,4-Substituted Thiazoles as Ampk Activators DR. REDDY'S LABORATORIES LTD. (IN) 2008-09-11 US disclosed
WO-2007002461-A1 3,4-SUBSTITUTED THIAZOLES AS AMPK ACTIVATORS DR. REDDY'S LABORATORIES LTD. (IN) 2007-01-04 WO disclosed
WO-2007002461-A1 3,4-SUBSTITUTED THIAZOLES AS AMPK ACTIVATORS DR. REDDY'S LABORATORIES LTD. (IN) 2007-01-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080221088-A1 3,4-Substituted Thiazoles as Ampk Activators PRKAG3, PRKAG1, PRKAG2 DHODH 3268/4885KDR 2007/4885GRM4 1968/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.